Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy M Delfi, R Sartorius, M Ashrafizadeh, E Sharifi, Y Zhang, P De Berardinis, ... Nano Today 38, 101119, 2021 | 158 | 2021 |
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses P De Berardinis, R Sartorius, C Fanutti, RN Perham, G Del Pozzo, ... Nature biotechnology 18 (8), 873-876, 2000 | 122 | 2000 |
Viral emerging diseases: challenges in developing vaccination strategies M Trovato, R Sartorius, L D’Apice, R Manco, P De Berardinis Frontiers in immunology 11, 570590, 2020 | 110 | 2020 |
Mesoporous bioactive glasses in cancer diagnosis and therapy: stimuli‐responsive, toxicity, immunogenicity, and clinical translation E Sharifi, A Bigham, S Yousefiasl, M Trovato, M Ghomi, Y Esmaeili, ... Advanced Science 9 (2), 2102678, 2022 | 97 | 2022 |
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments M Gaubin, C Fanutti, Z Mishal, A Durrbach, P De Berardinis, R Sartorius, ... DNA and cell biology 22 (1), 11-18, 2003 | 83 | 2003 |
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking P Makvandi, M Chen, R Sartorius, A Zarrabi, M Ashrafizadeh, ... Nano Today 40, 101279, 2021 | 78 | 2021 |
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines R Sartorius, M Trovato, R Manco, L D’Apice, P De Berardinis npj Vaccines 6 (1), 127, 2021 | 70 | 2021 |
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses R Sartorius, P Pisu, L D’Apice, L Pizzella, C Romano, G Cortese, ... The Journal of Immunology 180 (6), 3719-3728, 2008 | 69 | 2008 |
Vaccination with filamentous bacteriophages targeting DEC‐205 induces DC maturation and potent anti‐tumor T‐cell responses in the absence of adjuvants R Sartorius, C Bettua, L D'Apice, A Caivano, M Trovato, D Russo, I Zanoni, ... European journal of immunology 41 (9), 2573-2584, 2011 | 63 | 2011 |
Antigen delivery by filamentous bacteriophage fd displaying an anti‐DEC‐205 single‐chain variable fragment confers adjuvanticity by triggering a TLR 9‐mediated immune response R Sartorius, L D'Apice, M Trovato, F Cuccaro, V Costa, MG De Leo, ... EMBO molecular medicine 7 (7), 973-988, 2015 | 44 | 2015 |
Nonspherical metal‐based nanoarchitectures: synthesis and impact of size, shape, and composition on their biological activity EN Zare, X Zheng, P Makvandi, H Gheybi, R Sartorius, CKY Yiu, M Adeli, ... Small 17 (17), 2007073, 2021 | 43 | 2021 |
Arming filamentous bacteriophage, a nature-made nanoparticle, for new vaccine and immunotherapeutic strategies R Sartorius, L D’Apice, A Prisco, P De Berardinis Pharmaceutics 11 (9), 437, 2019 | 40 | 2019 |
Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex GJ Domingo, A Caivano, R Sartorius, P Barba, M Bäckström, ... Vaccine 21 (13-14), 1502-1509, 2003 | 39 | 2003 |
Cell loaded hydrogel containing Ag‐doped bioactive glass–ceramic nanoparticles as skin substitute: antibacterial properties, immune response, and scarless cutaneous wound … E Sharifi, SA Sadati, S Yousefiasl, R Sartorius, M Zafari, L Rezakhani, ... Bioengineering & Translational Medicine 7 (3), e10386, 2022 | 37 | 2022 |
Co-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells JP Jaworski, SJ Krebs, M Trovato, DN Kovarik, Z Brower, WF Sutton, ... PloS one 7 (2), e31464, 2012 | 37 | 2012 |
Recombinant filamentous bacteriophages encapsulated in biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses R Jamaledin, R Sartorius, C Di Natale, R Vecchione, P De Berardinis, ... Microorganisms 8 (5), 650, 2020 | 32 | 2020 |
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection PD Berardinis, R Sartorius, A Caivano, D Mascolo, GJ Domingo, ... Current HIV Research 1 (4), 441-446, 2003 | 30 | 2003 |
HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses … A Caivano, NA Doria-Rose, B Buelow, R Sartorius, M Trovato, L D'Apice, ... Virology 407 (2), 296-305, 2010 | 28 | 2010 |
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems L D’Apice, R Sartorius, A Caivano, D Mascolo, G Del Pozzo, DS Di Mase, ... Vaccine 25 (11), 1993-2000, 2007 | 28 | 2007 |
Nanobased platforms for diagnosis and treatment of COVID-19: from benchtop to bedside E Bidram, Y Esmaeili, A Amini, R Sartorius, FR Tay, L Shariati, ... ACS Biomaterials Science & Engineering 7 (6), 2150-2176, 2021 | 26 | 2021 |